Current and Future Opportunities for Rapid Diagnostics in Antimicrobial Stewardship

Medical Clinics of North America

Volumn 102, Issue 5, 2018, Pages 899-911

  Timbrook, Tristan T ^a   Spivak, Emily S ^b   Hanson, Kimberly E ^b,c  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

Author keywords

Antimicrobial stewardship; Diagnostic stewardship; Infections; Rapid diagnostics

Indexed keywords

ANTIBIOTIC AGENT; PEPTIDE NUCLEIC ACID; ANTIINFECTIVE AGENT;

ANTIMICROBIAL STEWARDSHIP; BLOODSTREAM INFECTION; FLUORESCENCE IN SITU HYBRIDIZATION; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL INFECTION; HUMAN; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PATIENT CARE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; ANTIBIOTIC RESISTANCE; DRUG EFFECT; GASTROINTESTINAL DISEASE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; ORGANIZATION AND MANAGEMENT; PROCEDURES; SEPSIS; TIME FACTOR;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL STEWARDSHIP; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MICROBIAL; GASTROINTESTINAL DISEASES; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGICAL TECHNIQUES; RESPIRATORY TRACT INFECTIONS; SEPSIS; TIME FACTORS;

EID: 85049794235     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2018.05.004     Document Type: Review

References (59)

1. Forrest, G.N., Roghmann, M.C., Toombs, L.S., et al. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 52:10 (2008), 3558–3563.
2. Banerjee, R., Teng, C.B., Cunningham, S.A., et al. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis 61:7 (2015), 1071–1080.
3. Barlam, T.F., Cosgrove, S.E., Abbo, L.M., et al. Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the society for healthcare epidemiology of America. Clin Infect Dis 62:10 (2016), e51–e77.
4. Frye, A.M., Baker, C.A., Rustvold, D.L., et al. Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia. J Clin Microbiol 50:1 (2012), 127–133.
5. Cosgrove, S.E., Li, D.X., Tamma, P.D., et al. Use of PNA FISH for blood cultures growing Gram-positive cocci in chains without a concomitant antibiotic stewardship intervention does not improve time to appropriate antibiotic therapy. Diagn Microbiol Infect Dis 86:1 (2016), 86–92.
6. Holtzman, C., Whitney, D., Barlam, T., et al. Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention. J Clin Microbiol 49:4 (2011), 1581–1582.
7. Pancholi, P., Carroll, K.C., Buchan, B.W., et al. Multicenter evaluation of the accelerate phenotest BC Kit for rapid identification and phenotypic antimicrobial susceptibility testing using morphokinetic cellular analysis. J Clin Microbiol, 2018, 10.1128/JCM.01329-17.
8. Forrest, G.N., Mehta, S., Weekes, E., et al. Impact of rapid in situ hybridization testing on coagulase-negative staphylococci positive blood cultures. J Antimicrob Chemother 58:1 (2006), 154–158.
9. Bauer, K.A., West, J.E., Balada-Llasat, J.M., et al. An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis 51:9 (2010), 1074–1080.
10. Perez, K.K., Olsen, R.J., Musick, W.L., et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 137:9 (2013), 1247–1254.
11. Huang, A.M., Newton, D., Kunapuli, A., et al. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 57:9 (2013), 1237–1245.
12. Walker, T., Dumadag, S., Lee, C.J., et al. Clinical impact of laboratory implementation of verigene BC-GN microarray-based assay for detection of gram-negative bacteria in positive blood cultures. J Clin Microbiol 54:7 (2016), 1789–1796.
13. MacVane, S.H., Hurst, J.M., Boger, M.S., et al. Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant Enterococcal bacteremia. Infect Dis (Lond) 48:10 (2016), 732–737.
14. Cairns, K.A., Doyle, J.S., Trevillyan, J.M., et al. The impact of a multidisciplinary antimicrobial stewardship team on the timeliness of antimicrobial therapy in patients with positive blood cultures: a randomized controlled trial. J Antimicrob Chemother 71:11 (2016), 3276–3283.
15. Timbrook, T.T., Morton, J.B., McConeghy, K.W., et al. The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clin Infect Dis 64:1 (2017), 15–23.
16. McElvania TeKippe, E., The added cost of rapid diagnostic testing and active antimicrobial stewardship: is it worth it?. J Clin Microbiol 55:1 (2017), 20–23.
17. Patel, T.S., Kaakeh, R., Nagel, J.L., et al. Cost analysis of implementing matrix-assisted laser desorption ionization-time of flight mass spectrometry plus real-time antimicrobial stewardship intervention for bloodstream infections. J Clin Microbiol 55:1 (2017), 60–67.
18. Brown, J., Paladino, J.A., Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model. Pharmacoeconomics 28:7 (2010), 567–575.
19. Wilson, N.A.G., Tibbetts, R.J., Samuel, L.P., et al. T2 magnetic resonance assay improves timely management of Candidemia. J Antimicrob Steward 1:1 (2017), 12–18.
20. Garey, K.W., Rege, M., Pai, M.P., et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43:1 (2006), 25–31.
21. Patel, G.P., Simon, D., Scheetz, M., et al. The effect of time to antifungal therapy on mortality in Candidemia associated septic shock. Am J Ther 16:6 (2009), 508–511.
22. Forrest, G.N., Mankes, K., Jabra-Rizk, M.A., et al. Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs. J Clin Microbiol 44:9 (2006), 3381–3383.
23. Heil, E.L., Daniels, L.M., Long, D.M., et al. Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections. Am J Health Syst Pharm 69:21 (2012), 1910–1914.
24. Bilir, S.P., Ferrufino, C.P., Pfaller, M.A., et al. The economic impact of rapid Candida species identification by T2Candida among high-risk patients. Future Microbiol 10:7 (2015), 1133–1144.
25. Walker, B., Powers-Fletcher, M.V., Schmidt, R.L., et al. Cost-effectiveness analysis of multiplex PCR with magnetic resonance detection versus empiric or blood culture-directed therapy for management of suspected Candidemia. J Clin Microbiol 54:3 (2016), 718–726.
26. Brendish, N.J., Malachira, A.K., Armstrong, L., et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med 5:5 (2017), 401–411.
27. Rappo, U., Schuetz, A.N., Jenkins, S.G., et al. Impact of early detection of respiratory viruses by multiplex PCR assay on clinical outcomes in adult patients. J Clin Microbiol 54:8 (2016), 2096–2103.
28. Green, D.A., Hitoaliaj, L., Kotansky, B., et al. Clinical utility of on-demand multiplex respiratory pathogen testing among adult outpatients. J Clin Microbiol 54:12 (2016), 2950–2955.
29. Semret, M., Schiller, I., Jardin, B.A., et al. Multiplex respiratory virus testing for antimicrobial stewardship: a prospective assessment of antimicrobial use and clinical outcomes among hospitalized adults. J Infect Dis 216:8 (2017), 936–944.
30. Hersh, A.L., Shapiro, D.J., Pavia, A.T., et al. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics 128:6 (2011), 1053–1061.
31. Schuetz, P., Wirz, Y., Sager, R., et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis 18:1 (2018), 95–107.
32. Timbrook, T., Maxam, M., Bosso, J., Antibiotic discontinuation rates associated with positive respiratory viral panel and low procalcitonin results in proven or suspected respiratory infections. Infect Dis Ther 4:3 (2015), 297–306.
33. Parente, D.M., Cunha, C.B., Mylonakis, E., et al. The Clinical utility of methicillin resistant Staphylococcus aureus (MRSA) nasal screening to rule out MRSA pneumonia: a diagnostic meta-analysis with antimicrobial stewardship implications. Clin Infect Dis, 2018, 10.1093/cid/ciy024.
34. Smith, M.N., Erdman, M.J., Ferreira, J.A., et al. Clinical utility of methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction assay in critically ill patients with nosocomial pneumonia. J Crit Care 38 (2017), 168–171.
35. Willis, C., Allen, B., Tucker, C., et al. Impact of a pharmacist-driven methicillin-resistant Staphylococcus aureus surveillance protocol. Am J Health Syst Pharm 74:21 (2017), 1765–1773.
36. Koo, H.L., Van, J.N., Zhao, M., et al. Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates. Infect Control Hosp Epidemiol 35:6 (2014), 667–673.
37. Truong, C.Y., Gombar, S., Wilson, R., et al. Real-time electronic tracking of diarrheal episodes and laxative therapy enables verification of clostridium difficile clinical testing criteria and reduction of clostridium difficile infection rates. J Clin Microbiol 55:5 (2017), 1276–1284.
38. Buckel, W.R., Avdic, E., Carroll, K.C., et al. Gut check: Clostridium difficile testing and treatment in the molecular testing era. Infect Control Hosp Epidemiol 36:2 (2015), 217–221.
39. Ahmad, S.M., Blanco, N., Dewart, C.M., et al. Laxative use in the setting of positive testing for Clostridium difficile infection. Infect Control Hosp Epidemiol 38:12 (2017), 1513–1515.
40. Brumley, P.E., Malani, A.N., Kabara, J.J., et al. Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection. J Antimicrob Chemother 71:3 (2016), 836–840.
41. Jury, L.A., Tomas, M., Kundrapu, S., et al. A Clostridium difficile infection (CDI) stewardship initiative improves adherence to practice guidelines for management of CDI. Infect Control Hosp Epidemiol 34:11 (2013), 1222–1224.
42. Welch, H.K., Nagel, J.L., Patel, T.S., et al. Effect of an antimicrobial stewardship intervention on outcomes for patients with Clostridium difficile infection. Am J Infect Control 44:12 (2016), 1539–1543.
43. Polen, C.B., Judd, W.R., Ratliff, P.D., et al. Impact of real-time notification of Clostridium difficile test results and early initiation of effective antimicrobial therapy. Am J Infect Control, 2018, 10.1016/j.ajic.2017.11.010.
44. Beal, S.G., Tremblay, E.E., Toffel, S., et al. A gastrointestinal PCR panel improves clinical management and lowers health care costs. J Clin Microbiol, 56(1), 2018 [pii:e01457-17].
45. Raux, B.R., Aldhaeefi, M., Steed, L.L., et al. Utilization of filmarray gastrointestinal panel (GIP) results on altering empiric antibiotic (ABX) use in patients with acute diarrhea. Open Forum Infect Dis, 4(suppl_1), 2017, S604.
46. ISRCTNregistry. Point-of-care testing for gastrointestinal pathogens. 2018. Available at: www.isrctn.com/ISRCTN88918395. Accessed February 9, 2018.
47. Goldenberg, S.D., Bacelar, M., Brazier, P., et al. A cost benefit analysis of the Luminex xTAG gastrointestinal pathogen panel for detection of infectious gastroenteritis in hospitalised patients. J Infect 70:5 (2015), 504–511.
48. Donner, L.M., Campbell, W.S., Lyden, E., et al. Assessment of rapid-blood-culture-identification result interpretation and antibiotic prescribing practices. J Clin Microbiol 55:5 (2017), 1496–1507.
49. Messacar, K., Hurst, A.L., Child, J., et al. Clinical impact and provider acceptability of real-time antimicrobial stewardship decision support for rapid diagnostics in children with positive blood culture results. J Pediatric Infect Dis Soc 6:3 (2017), 267–274.
50. Messacar, K., Parker, S.K., Todd, J.K., et al. Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship. J Clin Microbiol 55:3 (2017), 715–723.
51. Wenzler E, Timbrook T, Wong J, et al. Implementation and optimization of molecular rapid diagnostics in bloodstream infections: a clinical review. Am J Health Syst Pharm, in press.
52. Dellinger, R.P., Levy, M.M., Rhodes, A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41:2 (2013), 580–637.
53. Kumar, A., Ellis, P., Arabi, Y., et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136:5 (2009), 1237–1248.
54. T2Biosystems. T2Bacteria panel. 2018. Available at: www.t2biosystems.com/t2sepsis-solution/t2bacteria-panel/. Accessed February 9, 2018.
55. ClinicalTrials.gov. Clinical Evaluation of FilmArray LRTI Panel. 2018. Available at: clinicaltrials.gov/ct2/show/NCT02929680. Accessed February 9, 2018.
56. Ginsburg, G.S., Woods, C.W., The host response to infection: advancing a novel diagnostic paradigm. Crit Care, 16(6), 2012, 168.
57. Holcomb, Z.E., Tsalik, E.L., Woods, C.W., et al. Host-based peripheral blood gene expression analysis for diagnosis of infectious diseases. J Clin Microbiol 55:2 (2017), 360–368.
58. Tsalik, E.L., Petzold, E., Kreiswirth, B.N., et al. Advancing diagnostics to address antibacterial resistance: the diagnostics and devices committee of the antibacterial resistance leadership group. Clin Infect Dis 64:suppl_1 (2017), S41–S47.
59. Antibacterial Resistance Leadership Group. Studies In Progress. 2017. Available at: www.arlg.org/studies-in-progress. Accessed February 9, 2018.